Significant reduction in runny nose symptoms (P<0.01) vs placebo (Weeks 4, 8, and 12)
*Randomized, double-blind study (N=69) in children with perennial allergic rhinitis comparing ZYRTEC® (n=19) and placebo (n=16) over 12 weeks. Primary endpoint was change in mean rhinorrhea score during treatment.
Rhinorrhea = nasal discharge (runny nose).
Reference: 1. Lai DS, et al./ Ann Allergy Asthma Immunol. 2002;89(6):589-598.